StockDriftsStockDriftsTop 3 Vantage Consulting Group Inc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| BW | Babcock & Wilcox Enterprises Inc. | 77.68% | 2.42M | $15.3M | +0.00%(+0) | $5.93(+209.18%) | 2025-12-31 | |
| ADCT | ADC Therapeutics SA | 12.23% | 683.0K | $2.4M | +0.00%(+0) | $32.50(-86.55%) | 2025-12-31 | |
| CBUS | Cibus, Inc. | 10.09% | 1.14M | $2.0M | +0.00%(+0) | $14.25(-89.89%) | 2025-12-31 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative | 5-Year Annualized | 5-Year Cumulative |
|---|---|---|---|---|
| Top 20 Holdings Weighted | +21.52% | +79.47% | +6.59% | +37.60% |
| Top 20 Holdings Unweighted | +35.75% | +150.19% | +26.29% | +221.19% |
Vantage Consulting Group Inc reports $19.72M in US-listed equity holdings across 3 positions in its most recent 13F filing. Its largest disclosed positions are BW (77.7%), ADCT (12.2%) and CBUS (10.1%). The top 20 holdings account for 100% of reported assets. Its disclosed equity book has returned +79.47% on a three-year cumulative basis. Figures reflect the Q4 2025 filing.
Sign up free to track Vantage Consulting Group Inc, compare funds side by side, and get alerts the moment positions change.
Holdings on this page are parsed from Vantage Consulting Group Inc’s Form 13F filings with the U.S. Securities and Exchange Commission (CIK 1843547). View Vantage Consulting Group Inc’s 13F filings on SEC